Category Archives: Health

Empowering the Future of Personalized Medicine Through Co-Creation: Forging A Path With NalaGenetics and Zurich Insurance

This article was based on an interview with Mr Ally Robertson, Chief Operations Officer, Zurich Malaysia; Ms Levana Sani, Co-Founder and CEO, Nalagenetics and Ms Kamonlawan Chomchopbun, Product Manager and Market Access Lead, NalaGenetics.

Personalized medicine marks a turning point in healthcare, where treatments and preventive care are tailored to an individual’s unique genetic makeup. The approach seems very daunting with genetic testing becoming one of the key components, however, companies like Zurich Insurance Group (Zurich) and NalaGenetics are forging ahead to not only make it a standard but the norm. NalaGenetics, an innovative startup specializing in genetic testing is one of the finalists of the Zurich Innovation Championship (ZIC). As part of its journey in the ZIC, NalaGenetics has the unique opportunity to work with Zurich. This collaboration is breaking new ground by co-creating solutions that could revolutionize how healthcare and insurance work together to deliver preventive care that is both personalized and efficient.

A Doctor Talking the Patient
Photo by cottonbro

As healthcare and treatment options become more data-driven and proactive, Zurich and NalaGenetics are showing how co-creation and innovation can lead to powerful outcomes that improve individual health and reshape the broader insurance landscape. The collaboration also allows Zurich to be ahead of the curve and adopt a more agile approach to its key businesses.

The Zurich Innovation Championship: Catalysing Change and Empowering InsurTech Agility

Let’s start at the very beginning of this collaboration with the Zurich Innovation Championship (ZIC). Founded in 2018, the ZIC was designed to connect Zurich with startups that offer cutting-edge solutions to some of the most pressing challenges in the insurance industry. At its core, ZIC accelerates innovation by working with agile, experimental startups like NalaGenetics, which can bring fresh perspectives and technical prowess to Zurich’s century-old business.


Zurich MY Ally Robertson sq
Source: Zurich

“The Zurich Innovation Championship is about bringing innovative thinking and technology closer to Zurich. We work with startups like NalaGenetics to deliver faster, more effective solutions that can fundamentally change how we connect with our customers.”

Ally Robertson,
Chief Operations Officer, Zurich Malaysia


As Zurich seeks to maintain its competitive edge and better serve its customers in a rapidly changing world, the ZIC enables the company to tap into external innovation. Since its inception, the ZIC has seen over 7,000 submissions, resulting in over 70 pilots, 50 active initiatives, and a presence in over 30 countries. The collaboration with NalaGenetics in Malaysia stands as a prime example of how Zurich uses co-creation to solve real-world problems and modernize its offerings.

NalaGenetics Spearheading Genetic Relevance in Healthcare with Personalized Medicine

Let’s talk a little about NalaGenetics, one of the winners of the recent ZIC. NalaGenetics was founded on the belief that genetic testing could radically improve how patients are diagnosed and treated, particularly when it comes to drug metabolism, disease prevention, and overall health management. The company specializes in creating genetic tests that can predict how individuals will respond to medications, helping physicians tailor treatments more accurately to reduce adverse reactions and improve health outcomes.

In a world where medications are often designed based on a “one-size-fits-all” approach, NalaGenetics offers a much-needed alternative. Genetic testing can reveal how certain populations, such as Asians, metabolize drugs differently. This is even more pertinent with recent studies showing an increasing disparity between genetic populations and treatment efficacy. One such study highlights that 40-50% of Asians don’t respond well to the commonly prescribed anti-platelet medication Clopidogrel. It goes on to present data that shows that this population also sees an increased risk of cardiovascular events when prescribed Clopidogrel.

StockSnap DNA
Photo by Bango Renders on StockSnap

By leveraging genetic data, NalaGenetics allows physicians to make better-informed decisions, prescribing appropriate medications and lifestyle adjustments to their patients. But, as NalaGenetics’ founders quickly realized, providing genetic information alone isn’t enough—it’s essential to ensure patients take action based on these insights. That’s where NalaGenetics’ holistic approach comes in, combining genetic testing with physician-guided prevention programs to help patients improve their health outcomes.

Shaping the Future of Health and InsurTech with Co-Creation

As part of the Zurich Innovation Championship, Zurich in Malaysia and NalaGenetics entered into a unique collaboration that involves the co-creation of a solution that can impact the healthcare and insurance industries. Unlike traditional collaborations where a startup might deliver a product and then step aside, Zurich and NalaGenetics have adopted a more collaborative approach. Over a 3- to 6-month accelerator phase, both companies worked together in an agile, co-creative process to design a solution that aligns with Zurich’s goals of delivering personalized, preventive care through its life insurance and family takaful products.

“Co-creation is key to what we do,” Ally Robertson, Chief Operations Officer, Zurich Malaysia emphasized. “We don’t just invest in these startups. We work together, Zurich and NalaGenetics experts, in an iterative, agile manner to find solutions that solve real-world problems.”

Man Wearing White Long-sleeved Shirt Holding Black Pen
Photo by fauxels

During this period, both companies collaborated closely, sharing relevant data, insights, and expertise. They tested different product models, gathered customer feedback, and refined their offerings based on real-world data. The pilot program initially targeted existing Zurich Malaysia customers, offering genetic testing followed by personalized health advice from physicians. This was then expanded to new customers, with a focus on integrating preventive care into Zurich’s life insurance policies.

The co-creation process allows Zurich to respond to the market’s evolving needs, particularly as more customers seek health solutions that go beyond traditional insurance. The feedback from both customers and Zurich agents in Malaysia has been overwhelmingly positive. Agents, who initially approached the program cautiously, were so impressed after trying the service themselves that they became enthusiastic advocates, helping to drive customer interest and engagement.

Championing Personalized Medicine and Creating a New Standard in Healthcare and Insurance

The integration of personalized medicine into insurance is one of the most exciting developments in both industries. Genetic testing is becoming a crucial tool in preventive healthcare, allowing doctors to tailor treatments to individual patients and prevent costly medical conditions before they arise.

As part of their collaboration, Zurich and NalaGenetics aim to make personalized, preventive care a cornerstone of Zurich’s health insurance offerings. The aim is to enhance health outcomes and decrease long-term insurance claims by managing health risks at an early stage.


NalaGenetics Levana Sani sq
Source: NalaGenetics

“It’s about more than just selling a product—it’s about giving customers the tools they need to live healthier, longer lives. Even when we design products, we meet the doctors in the middle, we always ask them whether or not this truly benefits care – is there a true clinical decision point that we helped them address?”

Levana Sani,
Co-Founder and CEO, Nalagenetics


In practical terms, the program involves offering genetic tests to customers, followed by regular consultations with physicians to discuss the results and make necessary lifestyle adjustments. For example, if a patient’s genetic test reveals they are at high risk for cardiovascular disease, their physician can prescribe preventive measures, such as changes in diet or early medication interventions, to mitigate the risk before it becomes a serious issue.

The Benefits of Co-Creation: Early Results from the Pilot

The benefits of leveraging genetic testing and insights in this co-creation process are already apparent. During the pilot phase, Zurich Malaysia and NalaGenetics tested their product on a group of customers, gathering valuable data to refine their approach. One of the key takeaways was the high level of customer interest in genetic testing—80% of surveyed customers expressed a desire to undergo genetic testing, and 90% were willing to participate in associated health programs.

Customers also appreciated Zurich’s move away from traditional insurance or takaful products toward something more personalized and proactive. During the interview, Kamonlawan Chomchopbun, Product Manager and Market Access Lead at NalaGenetics who works on the ground with the Zurich Malaysia team, shared that even agents are empowered by the solution. The impact of the co-created solution was so immense that the agent shared, “It’s not just about offering coverage anymore—it’s about caring for the customer’s overall well-being.”

A Pediatrician Checking Up the Baby Girl Sitting on the Bed
Photo by Los Muertos Crew

Feedback from customers participating in the program revealed that they valued having a deeper understanding of their health risks and felt empowered to take preventive action. In one notable case, a patient with persistent GERD (gastroesophageal reflux disease) discovered through genetic testing that they had a mild lactose intolerance and a sensitivity to coffee. By making simple adjustments to their diet, the patient’s symptoms improved dramatically within three months, eliminating the need for further doctor visits.

This kind of personalized, preventive approach not only improves patient outcomes but also reduces the likelihood of costly insurance claims, creating a mutually beneficial relationship for both customers and Zurich.

A Glimpse into the Future: Data-Driven Decisions and Preventive Care

Looking ahead, the collaboration between Zurich and NalaGenetics can have a lasting impact on both the health and insurance industry. As more data is gathered through genetic testing and preventive care programs, Zurich will be able to make more informed decisions about how to cater to the evolving needs of its clients while helping them optimize health outcomes. The potential for AI-driven insights, automation and more significantly genetic insights will undoubtedly play an increasing role in shaping the future of healthcare and insurance.


Zurich MY Ally Robertson sq
Source: Zurich

“If we look ahead to 2030, we’ll see more data-driven decisions in every part of life. Insurance products will need to modernize alongside this trend, offering customers not just coverage but proactive solutions that help them live healthier lives.”

Ally Robertson,
Chief Operations Officer, Zurich Malaysia


As the collaboration evolves, both companies expect the demand for personalized medicine to grow, particularly in regions like Southeast Asia, where genetic differences often mean that standard treatments are less effective. The insights gathered from this co-creation process will be invaluable in shaping Zurich’s future offerings and making personalized care a mainstream component of health insurance. It will also help make genetic testing the standard when it comes to treatment plans and optimizing patient care.

Pioneering the Future of Personalized Healthcare

The co-creation between NalaGenetics and Zurich is a powerful example of how collaborations between startups and established corporations can drive meaningful change. Through the Zurich Innovation Championship, the companies are poised to bring personalized medicine into the insurance space. The co-creation process has allowed them to offer customers more than just peace of mind, they’re offering the tools to live healthier, longer lives.

By focusing on genetic testing, preventive care, and data-driven solutions, Zurich and NalaGenetics are paving the way for a future where healthcare and insurance are fully integrated, providing a holistic approach to well-being. This collaboration not only sets Zurich Malaysia apart in the insurance market but also offers a glimpse into the future of personalized, proactive healthcare.

As the world continues to evolve, one thing is clear: the future of healthcare is personal, and Zurich and NalaGenetics are leading the way.

This article was based on an interview with Mr Ally Robertson, Chief Operations Officer, Zurich Malaysia; Ms Levana Sani, Co-Founder and CEO, Nalagenetics and Ms Kamonlawan Chomchopbun, Product Manager and Market Access Lead, NalaGenetics.

Zurich MY Ally Robertson

Alastair Robertson (Ally)
Country Chief Operations Officer (COO)
Zurich Malaysia

Ally is an experienced industry professional with over 16 years of experience in the insurance industry. He has helmed various leadership roles across Strategy, Transformation and Operational Excellence. He has experience in leading large-scale change teams, focusing on Lean Thinking, Automation and AI.

He also has cross-functional experience, which includes P&C, Life, Claims, Group, Underwriting & Shared Services and has extensive knowledge of working with suppliers both on and offshore. Prior to his current appointment, Ally held the role of Head of Enterprise Transformation at Zurich Australia and New Zealand and has experience working across five different continents while at Zurich.

Ally is highly energetic and has the ability to connect, influence and develop collaborative business relationships at all levels. Given his experience working on different continents, he is well-versed in managing diverse teams while driving a real sense of togetherness and team spirit that is focused on business outcomes.

NalaGenetics Levana Sani 2

Levana Sani
Co-Founder & Chief Executive Officer, NalaGenetics

Levana Sani is the co-founder and CEO of NalaGenetics, a biotechnology startup transforming personalized healthcare through advanced predictive genetic testing for diverse populations. NalaGenetics addresses the limitations of traditional germline sequencing by combining monogenic risk, polygenic risk, and clinical risk scores, enabling healthcare providers to offer more sensitive, comprehensive, and cost-effective testing solutions for cardiovascular, metabolic, cancer, and neurodegenerative conditions. 

Levana studied biochemistry, genetics, and business and holds a Bachelor of Biochemistry from the University of Southern California followed by an MBA from Harvard Business School. While being a part of the Genome Institute of Singapore, Levana and a team of scientists founded NalaGenetics in 2016. Her contributions to NalaGenetics led to Levana being selected in the Forbes 30 under 30 in 2021. 

In 2022, NalaGenetics became a part of Singapore’s SG100K study, aimed at mapping genomes of 10,000 participants to advance precision medicine and prevent chronic diseases in Singaporean and other Asian populations. Today, NalaGenetics’ solutions are offered by a growing number of healthcare providers and laboratories in Asia and Europe, reflecting the company’s exceptional standards and depth of research as a scientist-led company. 

Kamonlawan Chomchopbun

Kamonlawan Chomchopbun
Product Manager and Market Access Lead, NalaGenetics.

Kamonlawan is a seasoned product leader with extensive experience in genetic testing and healthcare solutions across Southeast Asia. As the Market Access and Product Lead at NalaGenetics, she oversees genetic test services, including product management, operations, and business monitoring. Her work focuses on driving innovative solutions like NalaCare™, a personalized wellness program aimed at improving customer engagement and satisfaction in insurance and healthcare. With a passion for making an impact through education, product development, and personalized healthcare, she has successfully led projects that blend science with real-world applications.

Kamonlawan holds a PhD in Pharmacy from the National University of Singapore, where her academic journey reinforced her commitment to medication safety and healthcare quality improvement.

Transforming Healthcare in Asia Pacific: The Impact of Medical Devices

This article is contributed by Bijay Singh, Global Head, Business Unit Healthcare at DKSH.

The Asia Pacific (APAC) region, home to 60% of the global population, is emerging as a key market for global medical device companies.[1] This shift is underscored by the potential of the APAC region, which encompasses a diverse array of cultures, languages, and socioeconomic backgrounds, and a healthcare market that has already surpassed Europe to become the second-largest market globally, right behind the United States.[2] Key drivers for this growth include rising income levels, an ageing population, and an increased prevalence of chronic diseases, all contributing to the heightened demand for medical devices.[3] However, the APAC region embodies a spectrum of healthcare systems, ranging from densely populated urban centres with state-of-the-art medical facilities to remote communities facing formidable barriers to access. These disparities in the healthcare space highlight the need for innovative solutions to transform the healthcare delivery system, addressing key issues such as access barriers and shortages of manpower and resources. This is where the crucial role of medical devices comes into play.

Population Dynamics across APAC

By 2050, the number of individuals aged 60 and above in the APAC region is projected to more than double, reaching a staggering 1.3 billion.[4]  This demographic trend brings with it a host of healthcare challenges, including an increased burden of age-related diseases and conditions such as cardiovascular diseases, cancer, and neurodegenerative disorders.[5]

Woman measuring her blood pressure while consulting with doctor via telemedicine at home
Source: DKSH / A woman is measuring her blood pressure while consulting with a doctor via telemedicine video call on a laptop at home

Alongside an ageing population, there is a marked increase in the prevalence of chronic and non-communicable diseases (NCDs) like diabetes, hypertension, and obesity, which collectively contribute to 41 million deaths each year, representing approximately 74% of global mortality. [6] In APAC, NCD-related deaths are prominent, with some countries reporting rates as high as 90% of total fatalities.[7] The lasting impact of the COVID-19 pandemic exacerbated these challenges, severely straining healthcare resources, disrupting routine care services, and revealing critical gaps in preparedness and response capabilities.[8] Healthcare facilities are grappling with issues like overcrowding, reduced physician-to-population ratios, limited medicine availability, and inadequate funding. Projections from the World Health Organisation (WHO) indicate an imminent global deficit by 2030, with Southeast Asia alone expected to account for 40% of this shortfall.[9] For instance, in 2023, Indonesia reported a deficit of 31,481 specialist doctors,[10] while the Philippines anticipates a 25-year timeline to achieve the ideal doctor-patient ratio.[11] These challenges are further compounded by factors such as rapid population growth, lifestyle shifts, urbanization, emigration of healthcare workers, and an ageing healthcare workforce.

Harmonising Healthcare with Medical Device Innovations

Amidst the growing demand for healthcare services, the medical devices sector stands as a burgeoning industry poised to reshape healthcare approaches. Analysts project that, by 2028, the Asian medical devices market will account for more than USD 156 billion in revenue.[12] The next frontier in healthcare innovation will involve an increased focus on the digitalisation of medical devices, thereby enhancing access, convenience, and patient-centred care.

In recent years, we are already seeing more medical devices being used across the healthcare system:

  • Remote monitoring and telemedicine: Medical devices, including wearable sensors, smart watches, remote monitoring devices, and telemedicine platforms, empower healthcare providers to remotely monitor patients’ vital signs, health status, and treatment adherence. This allows caregivers to monitor multiple patients simultaneously despite manpower shortages. For instance, the Dexcom G6 continuous glucose monitoring system, available in Singapore and Japan, allows for real-time monitoring, integrated with wearable sensors and a transmitter for the measurement of blood glucose values.
  • Point-of-care testing: Point-of-care testing devices offer rapid and convenient diagnostic capabilities outside of traditional laboratory settings. These devices can be particularly valuable in resource-limited settings or remote areas. For example, during the COVID-19 pandemic, multiple home-test kits were developed to allow the first round of testing at home. This also helped people adhere to the social distancing norms.
  • Self-management apps: Mobile health (mHealth) apps and devices empower patients to take an active role in managing their health and well-being. These apps enable users to track their exercise, diet, medication adherence, and vital signs, providing valuable insights into their health status and facilitating communication with healthcare providers.
  • Home-based care: Technological advancements have facilitated the development of home medical devices, and enhanced patient care convenience while reducing hospitalization expenses, promoting patient independence, and improving quality of life. Devices such as home infusion pumps, portable oxygen concentrators, and remote monitoring systems empower chronic patients to manage their health outside of traditional healthcare settings. DKSH’s service Home Pulse exemplifies this shift by delivering high-quality healthcare services directly to patients’ homes in Thailand. This approach has the potential to enhance the role of home-based medical devices, optimizing resource allocation and cutting overall healthcare costs for the future.

While the accelerated adoption of medical devices can transform the healthcare landscape, a critical challenge lies in enabling healthcare professionals (HCPs) to interpret collected data. This is a common industry issue, where a significant amount of data either falls through the cracks or becomes overwhelming, making it difficult to analyse and utilise effectively. Statistics paint a concerning picture, revealing that 97% of health data produced by hospitals remains unanalysed, and 46% of healthcare leaders view data management as a significant burden.[13] This translates to a vast reservoir of potentially life-saving insights remaining untapped. Hence, addressing the challenges of data interpretation will allow HCPs to unlock the true potential of medical devices and pave the way for personalised healthcare in APAC.

Collaborative Efforts to Propel Medical Devices Growth

In 2023, the region’s medical devices market reached a value of USD 111.93 billion, and projections suggest that it will further grow at a CAGR of 6.8% and reach USD 166.1 billion by 2029.[14] Driving this growth in APAC demands a collaborative approach involving government bodies, healthcare providers, academic institutions, and industry stakeholders.

Consulting doctor visit on mobile app at home.telemedicine
Source: DKSH / Consulting doctor visit via a mobile app at home i.e telemedicine

Regulatory developments play a pivotal role in strengthening the sector’s upward trajectory. Harmonising and streamlining regulatory frameworks are essential to facilitate faster approval and market entry of new medical devices. Regional agreements, like those within ASEAN[15] aim to establish consistent regulations, streamline approval processes, and enhance market access for medical devices across borders.[16] By aligning standards and regulations, regulatory bodies seek to create a more predictable and transparent environment for manufacturers, distributors, and healthcare providers.

Governments should incentivise research and development (R&D) through grants and tax benefits to stimulate local innovation of medical devices. Initiatives like Singapore’s National Health Innovation Centre (NHIC) and South Korea’s National Institute of Health (NIH) fund medical research and support clinical trials, often in collaboration with universities and healthcare companies, enabling efficient validation of new medical devices.[17] Training programs for healthcare professionals on the use of new devices are equally crucial to ensure their effective adoption and utilization. These efforts not only facilitate faster market entry but also ensure that innovations address specific healthcare needs in diverse APAC markets.

Additionally, healthcare distribution facilities are emerging as key growth drivers, streamlining supply chains and enhancing accessibility to medical devices across APAC. DKSH Healthcare’s OP1 in Taiwan, Asia’s largest automated healthcare distribution centre, utilizes advanced automation to expedite the distribution of healthcare solutions, including medical devices, across the region. Distribution centres such as this ensure efficient logistics and support timely delivery and inventory management, which is crucial for meeting healthcare demands in diverse markets. All in all, driving the medical devices sector forward in APAC involves a comprehensive approach to address regulatory, infrastructure, reimbursement, and training challenges while ensuring patient privacy, safety, and equity. Collaboration among healthcare stakeholders, technology developers, policymakers, and regulatory authorities is crucial to improving health outcomes. In this regard, DKSH Healthcare is committed to playing a vital role in this transformation by facilitating the distribution and adoption of innovative medical devices, empowering patients, optimizing resource allocation, and contributing to a healthier future for all in the region.


[1]https://asiapacific.unfpa.org/en/populationtrends#:~:text=The%20Asia%20and%20the%20Pacific,Developing%20States%20in%20the%20Pacific

[2]https://insights.omnia-health.com/management/navigating-growth-apac-regions-medical-device-landscape

[3]https://www.credenceresearch.com/report/medical-health-screening-services-market

[4]https://asiapacific.unfpa.org/en/populationtrends#:~:text=The%20Asia%20and%20the%20Pacific,Developing%20States%20in%20the%20Pacific.

[5]https://www.nature.com/articles/s41392-022-01251-0

[6]https://www.who.int/news-room/fact-sheets/detail/noncommunicable-diseases

[7]https://devpolicy.org/ncds-in-asia-and-the-pacific-recent-findings-and-key-challenges-20221116/#:~:text=According%20to%20the%20WHO%20report,also%20in%20the%20top%20ten.

[8]https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9354133/

[9]https://journals.lww.com/wsep/fulltext/2021/10001/implementing_a_decade_of_strengthening_the_health.15.aspx

[10]https://www.integrity-indonesia.com/blog/2023/10/10/overcoming-medical-workforce-shortages-opportunities-and-challenges-for-foreign-doctors-in-indonesia/#:~:text=According%20to%20a%20report%20from,serving%20a%20population%20of%20277%2C432%2C36

[11]https://www.philstar.com/headlines/2023/11/13/2311040/ideal-patient-doctor-ratio-seen-25-years-lawmaker

[12]https://www.statista.com/outlook/hmo/medical-technology/medical-devices/asia#revenue

[13]https://apacmed.org/wp-content/uploads/2023/08/APACMed-Power-Promise-of-Health-Data-Value_August-2023-2.pdf

[14] https://www.marketdataforecast.com/market-reports/apac-medical-devices-market

[15] https://www.aseanbriefing.com/news/aseans-free-trade-agreements-an-overview/

[16] https://asean.org/wp-content/uploads/2023/05/ASEAN-Guidelines-for-Harmonisation-of-Standards-2022-Version.pdf

[17] https://www.nih.go.kr/eng/  

Amazfit T-Rex 3 Released in Malaysia at RM1,099

Zepp Health has launched the Amazfit T-Rex 3, a rugged smartwatch designed for outdoor enthusiasts and adventurers. With its military-grade durability, precise navigation, and exceptional battery life, the T-Rex 3 is the perfect companion for your outdoor adventures.  

Amazfit T Rex 3
Source: Amazfit

The Amazfit T-Rex 3 is built to withstand the toughest conditions, featuring a rugged design and military-grade construction. Its large 1.5-inch AMOLED display offers a peak brightness of 2,000 nits, ensuring excellent visibility in any lighting conditions.  

The T-Rex 3 boasts a powerful battery that can last up to 27 days on typical usage or 180 hours of continuous GPS tracking and navigation. This impressive battery life allows you to embark on extended adventures without worrying about running out of power.  

Equipped with dual-band GPS, the T-Rex 3 provides accurate navigation and tracking, even in challenging environments. The smartwatch offers offline maps with turn-by-turn directions, ensuring you stay on course, even without cellular connectivity.  

Amazfit T Rex 3 Running
Source: Amazfit

Privacy is a top priority with the T-Rex 3. You have control over your GPS data, with options for permanent or temporary cloud storage, no cloud storage, or entirely disabling GPS permissions. Additionally, you can back up your data to your email, cloud, or mobile device.  

The T-Rex 3 offers a wide range of health-tracking features, including heart rate variability, blood oxygen monitoring, sleep tracking, and stress monitoring. These features help you understand your overall health and fitness levels.  

With over 170 workout modes, the T-Rex 3 caters to a variety of fitness activities. New additions include Hyrox Racing, Freediving, and upgraded Strength Training modes. The Zepp Coach feature provides personalized workout plans and guidance to help you reach your fitness goals.  

Amazfit T Rex 3 Gym
Source: Amazfit

The T-Rex 3 runs on Zepp OS 4.0, which introduces fully integrated AI for a smarter and more intuitive experience. Enjoy seamless connectivity with third-party fitness devices and benefit from the AI assistant powered by OpenAI’s GPT-4.

Comparison to the Amazfit T-Rex 2

The Amazfit T-Rex 3 builds upon the success of its predecessor, the T-Rex 2. Here’s a comparison of key features:

FeatureAmazfit T-Rex 2Amazfit T-Rex 3
Screen Size1.39 inches1.50 inches
Screen MaterialGlassGorilla Glass
Brightness1,000 nits2,000 nits
Built-in MicrophoneNoYes
Sports Modes158+170+
Operating SystemZepp OS 2.0Zepp OS 4.0

Pricing and Availability

The Amazfit T-Rex 3 is available for pre-order at a special price of RM1,099.00 during the Pre-Launch Sale from September 7th to 8th, 2024, at the DirectD Gadget Mega Store in Petaling Jaya. Customers will also receive a complimentary Amazfit String Bag, Amazfit Microfiber Towel, and DirectD Water Bottle while supplies last. Starting from September 9th, 2024, the T-Rex 3 will be available for RM1,099.00 on Shopee.  

Samsung’s Galaxy Watch is More Affordable with the Galaxy Watch FE

Samsung has expanded its wearable lineup with the introduction of the Galaxy Watch FE, a smartwatch designed to empower users of all fitness levels with advanced health monitoring technology. Building on the success of its predecessors, the FE (standing for “Fan Edition”) offers a compelling balance of features, design, and affordability.

Galaxy Watch FE Advanced Health Monitoring Thumbnail1000 KV

The Galaxy Watch FE prioritizes user well-being with a suite of advanced health-tracking features. Samsung’s Bioelectrical Impedance Analysis (BIA) sensor takes centre stage, providing users with in-depth insights into their body composition. This includes measurements of body fat percentage, skeletal muscle mass, body water, and basal metabolic rate (BMR). This valuable data, combined with traditional features like 24/7 heart rate monitoring, sleep tracking, and step counting, allows users to gain a comprehensive understanding of their overall health and fitness levels.

The Galaxy Watch FE boasts a comfortable and stylish design, perfect for integrating into your daily routine. The lightweight aluminium frame ensures comfortable wear throughout the day, while the choice of three colour options – Black, Pink Gold, and Silver – allows users to express their personal style. The 1.2-inch Super AMOLED display offers excellent readability even under bright sunlight, showcasing workout metrics, notifications, and watch faces with vibrant clarity.

my feature sapphire crystal glass durability redefined 542488170

Powering the Galaxy Watch FE is Samsung’s Exynos W920 dual-core processor, paired with 1.5GB of RAM. This combination ensures a smooth and responsive user experience, allowing users to navigate the watch’s interface and access features seamlessly. Additionally, the device boasts 16GB of internal storage, providing enough space to store your favourite workout playlists directly on the watch, eliminating the need for your phone during exercise sessions.

The Galaxy Watch FE seamlessly integrates with your Samsung Galaxy smartphone for enhanced functionality. Users can receive and manage notifications, make and receive calls, and control music playback directly from their wrist. This level of connectivity ensures you stay informed and entertained without needing to reach for your phone every time.

my feature customize it your watch your vibe 542488120

Beyond functionality, the Galaxy Watch FE encourages active lifestyles with built-in workout programs and activity challenges. Whether you prefer running, cycling, swimming, or other fitness routines, the watch offers a variety of options to keep you engaged. Additionally, real-time feedback on your performance helps you stay on track and achieve your fitness goals.

The Galaxy Watch FE is built to withstand the demands of an active lifestyle. With a 5ATM water resistance rating, the watch can handle swimming, showering, or exercising in the rain with ease. Additionally, it boasts dust and shock resistance, ensuring it can handle everyday wear and tear without worry.

Pricing & Availability

The Galaxy Watch FE is set for release in Malaysia on August 10th, 2024. The starting price for the Bluetooth variant is RM799.

OnePlus Hits the Refresh Button Unveils the Nord Buds 3 Pro and Watch 2R

OnePlus is on a roll! Hot on the heels of the Nord 4 and Pad 2 announcements, the company has unveiled two new wearables that cater to the budget-conscious and style-savvy user: the OnePlus Nord Buds 3 Pro and the OnePlus Watch 2R.

Nord Buds 3 Pro: Premium Sound Without Breaking the Bank

The Nord Buds 3 Pro earbuds ditch the plastic construction often found in mid-range options and instead boast a sleek and stylish design with a premium feel. They come in a variety of colours – think Starry Black and Soft Jade – so you can find a pair that complements your unique style. But the Nord Buds 3 Pro aren’t just about looks; they pack a punch in the audio department too.

OnePlus Nord Buds 3 Pro official 1 1420x1009 webp

Equipped with a hefty 12.4mm dynamic driver, these buds promise rich and detailed sound, perfect for audiophiles on the go. OnePlus has also thrown in support for Dolby Atmos, which creates a more immersive listening experience, making you feel like you’re right in the middle of your favourite tunes. Let’s face it, even the most stylish buds fall flat if the sound quality is lackluster. Thankfully, the Nord Buds 3 Pro seem to hit the mark here.

Active Noise Cancellation (ANC) for a Quiet Escape

One of the standout features of the Nord Buds 3 Pro is the inclusion of Active Noise Cancellation (ANC). This technology actively reduces unwanted background noise, allowing you to focus on your music, podcasts, or audiobooks without distractions. Whether you’re commuting on a noisy bus or trying to drown out the world at the gym, ANC can be a game-changer.

But here’s the kicker: ANC isn’t always desirable. Sometimes you need to be aware of your surroundings, like when you’re cycling or crossing a busy street. Thankfully, the Nord Buds 3 Pro offer a transparency mode that lets you hear ambient noise, ensuring you stay safe and connected to your environment.

Seamless Connectivity and Long Battery Life

OnePlus knows the importance of seamless connectivity. The Nord Buds 3 Pro boasts support for the latest Bluetooth 5.3 standard, ensuring a stable and reliable connection to your smartphone or tablet. Plus, with a claimed battery life of up to 6 hours for the buds themselves and an additional 30 hours with the charging case, you can listen to your favourite music all day long without worrying about running out of juice.

OnePlus Watch 2R: A Lighter and More Affordable Option

The OnePlus Watch 2R is the successor to the OnePlus Watch 2, but with a twist. It’s designed to be a more affordable and lightweight option while still offering the essential features you need in a smartwatch.

Gone is the bulky stainless steel construction of its predecessor. The Watch 2R embraces a sleek aluminium design, making it lighter and more comfortable to wear all day long. This shift in materials might raise a slight eyebrow in terms of durability, but the retained IP68 water resistance rating assures it can still handle sweat, rain, and accidental splashes.

OnePlus Watch 2R official image 1 1154x710 webp

Don’t be fooled by the lighter design; the Watch 2R packs a punch under the hood. It features a Qualcomm Snapdragon W5 Gen 1 chip paired with 2GB of RAM, ensuring smooth performance for running essential smartwatch functions. The 1.43-inch AMOLED display offers crisp visuals, and with a selection of watch faces to choose from, you can personalize your watch to match your style.

The OnePlus Watch 2R caters to the fitness enthusiast with a variety of built-in workout modes. Whether you’re a runner, cyclist, or swimmer, the watch can track your activity and provide valuable insights into your performance. It also boasts various health monitoring features, including heart rate tracking, blood oxygen monitoring, and sleep tracking, helping you stay on top of your overall well-being.

OnePlus Watch 2R official image 3 1420x874 webp

The Watch 2R runs on Google’s Wear OS, which offers a familiar and user-friendly experience. With access to Google Assistant and a growing library of apps, you can stay connected, informed, and motivated on the go. Plus, the promised long battery life of up to 12 days in power saver mode ensures you won’t need to constantly scramble for a charger.

Pricing & Availability

The OnePlus Nord Buds 3 Pro will be priced at a starting price of US$79.99 (approx. RM373.21). The OnePlus Watch 2R will be priced at USD$229.99 (approx. RM1,073.12). Both wearables will be available in multiple colour options, allowing you to choose the perfect combination that reflects your personality.

Pre-orders for the Nord Buds 3 Pro and Watch 2R are expected to begin on July 20th, with the first wave of sales starting on August 2nd.

Unpacking the Galaxy Watch Ultra, Galaxy Watch7 & the Galaxy Buds3 series

Samsung has just announced its new flagship wearables – expanding its Galaxy Watch series with the Galaxy Watch Ultra and revamping its Galaxy Buds series with the new Galaxy Buds3 and Galaxy Buds3 Pro. The new wearables are spearheaded by the Galaxy Ring. The new Samsung Galaxy Watch Ultra takes the Galaxy Watch to new frontiers with a new, more rugged look with features to match.

It also spearheads the Galaxy AI revolution when it comes to wearables with more intelligent and accurate tracking even in the Galaxy Watch7. The Galaxy Buds3 Series debuts with an all new design focusing on self expression and comfort. With the Galaxy Buds3 Pro, Samsung is bringing an all new way to enjoy your music and at even higher quality.

KAO Launches A New Way to Keep Mosquitoes at Bay

It’s not every day that a tech site covers health or cosmetics. However, this one had to be covered. KAO, the company behind some of Japan’s best cosmetic products has released a new way to help keep Dengue and other mosquito-borne diseases at bay. This new product is launching hot off the heels of the announcement of QDenga, a novel vaccine for dengue, in Malaysia.

Biore GUARD Mos Block Serum 1
Source: KAO

It may seem quite absurd to suddenly be going all out to keep diseases like Dengue and Chikungunya in check. However, Malaysia and many other tropical countries have long been plagued by these diseases. In 2023 alone, Malaysia saw an exponential increase in Dengue cases totalling about 123,133 cases – a whopping 86.3% compared to 2022. This coincided with a 78.6% increase in Dengue-related deaths. In the first quarter of 2024 alone, there have been 41,565 reported cases and 28 deaths. This again is a rise compared to last year. With an increasing disease burden, KAO is hoping that its new “Bioré GUARD Mos Block Serum” will be a valuable addition to reducing the disease burden in Malaysia and the rest of the world.

Using a Commonly Used Emulsifier to Keep Mosquitoes Away

KAO’s Bioré GUARD Mos Block Serum uses something that we’ve been using for ages in cosmetic products as its active ingredient – Silicone oil. Through research, the team at KAO realised that Silicone oil which is commonly used as an emulsifier in cosmetics has an unpredicted effect on mosquito behaviour.

Biore GUARD Mos Block Serum 2
(Source: KAO) The KAO Research Team showing the efficacy of the Bioré GUARD Mos Block Serum Live at the launch.

Their research showed that somehow, mosquitoes would not land on surfaces lined with Silicone oil. Through further observation, researchers realised that mosquitoes would also work to remove the residues after contact. Through further research, the team realised that Silicone oil also exerts a downward force that is equal to about 80% of the weight of the mosquito itself. Due to this, mosquitoes tend to be “repelled” from skin and surfaces lined with Silicone oil.

Thanks to these observations, KAO is using Silicone oil as its active ingredient in the Biore Mos Block Serum. This also means that the serum is inert and safe to use even on sensitive skin. When queried, the team affirms that the serum has been dermatologically tested and is safe even for infants and toddlers. Another plus point is the omission of harmful substances like diethyltoluamide (DEET) or Picardin or even harsh essential oils. These substances are known to cause adverse reactions in individuals with dermatological sensitivities.

Pricing & Availability

The Bioré GUARD Mos Block Serum is now available in most pharmacies for RM24.90 for 100g. It is available in two variants: Fresh Lavender and Sweet Blossom. KAO says that availability in other retail outlets will follow after the initial rollout in pharmacies.

Scientists Just Used AI to Discover New Genes Linked to Heart Disease

Heart disease remains the leading cause of death globally, impacting millions of lives each year. While significant progress has been made in understanding the risk factors associated with heart disease, the precise genetic underpinnings of this complex condition have remained largely elusive. However, a recent breakthrough involving artificial intelligence (AI) offers a glimpse into a future where personalized medicine for heart disease becomes a reality.

robina weermeijer z8 Fmfz06c unsplash
Photo by Robina Weermeijer on Unsplash

Heart disease is a multifaceted condition influenced by a combination of genetic and environmental factors. Traditional methods for identifying genes associated with disease often relied on genome-wide association studies (GWAS). These studies compare the genetic makeup of individuals with and without a particular disease, searching for variations (single nucleotide polymorphisms or SNPs) that occur more frequently in the diseased population. While GWAS have identified numerous SNPs linked to heart disease, many of these variants exert a relatively weak effect, making it challenging to pinpoint the specific genes responsible and develop targeted therapies.

Machine Learning Model Used to Gain More Insights by Researchers

Researchers at Icahn School of Medicine at Mount Sinai are pioneering the use of a novel AI tool to unlock the secrets hidden within our genes. This tool, called a machine learning-based marker (MLBM), takes a more sophisticated approach compared to traditional GWAS. Instead of simply analyzing individual SNPs, the MLBM leverages machine learning algorithms to identify complex patterns across hundreds of genetic variants. Imagine sifting through a vast library of books, searching not just for individual words but for nuanced patterns and connections between sentences and paragraphs. The MLBM operates in a similar fashion, analyzing the interplay between numerous genetic variations to identify those that collectively contribute to an increased risk of heart disease.

The MLBM’s ability to identify complex patterns within genetic data has yielded significant results. The research team used the MLBM to analyze electronic health records and genetic data from over 600,000 individuals. This analysis revealed not only common SNPs associated with heart disease but also a set of rare coding variants within 17 previously unknown genes. These rare variants, while individually occurring in a smaller proportion of the population, may exert a more significant impact on heart disease risk. Imagine finding a single, critical clue hidden amongst a mountain of seemingly unrelated information. The MLBM’s ability to identify these rare yet impactful genetic variations holds immense potential for uncovering new pathways involved in heart disease development.

digitale de MES6r7WFb0o unsplash
Photo by digitale.de on Unsplash

The identification of these novel genes opens doors for the development of more targeted therapies for heart disease. By understanding the specific genetic mutations contributing to an individual’s risk, doctors can potentially tailor treatment plans to address the underlying cause rather than simply manage symptoms. Imagine a future where preventive measures and medications can be personalized based on a person’s unique genetic makeup, potentially preventing heart disease altogether.

New Technologies Changing Medical Research

The success of the MLBM in uncovering new genetic variants for heart disease signifies a paradigm shift in our approach to medical research. AI has the potential to revolutionize the way we diagnose, treat, and ultimately prevent a wide range of diseases. By harnessing the power of AI to analyze complex biological data, researchers can gain a deeper understanding of the intricate dance between genes and disease. This newfound knowledge can pave the way for the development of personalized medicine, offering a future where healthcare becomes more proactive and effective in combating life-threatening conditions like heart disease.

watchOS 11 Puts the “Control” in “Take Control of Your Health”

Apple Watch has become an indispensable tool for many users, offering fitness tracking, communication features, and a convenient way to stay on top of notifications. Each iteration of WatchOS has brought many enhancements that make the experience of Apple Watches a little better. This year’s watchOS 11 update promises a range of enhancements focused on personalization, improved health insights, and expanded functionality, solidifying the Apple Watch’s position as a comprehensive and versatile wearable device. Let’s delve deeper into the key features shared at WWDC 2024.

Apple WWDC24 watchOS 11 Apple Watch 3 up 240610 big.jpg.large 2x
Source: Apple

Taking Control of Your Activity Rings

watchOS 11 introduces a new level of personalization for Activity rings. Imagine needing a break from your fitness routine due to an injury or a busy schedule. With watchOS 11, you can now pause your Activity rings for a day, a week, a month, or even longer. This allows you to maintain your award streak while taking a necessary break, ensuring a more flexible approach to fitness goals. Additionally, users can customize their Activity ring goals by day of the week. Imagine setting a more ambitious move goal for weekdays when you have more time for exercise, while setting a more relaxed target for weekends. This customization empowers users to tailor their Activity rings to their individual schedules and fitness aspirations.

The Vitals App: A Holistic View of Your Health

watchOS 11 introduces the Vitals app, offering a centralized location to view key health metrics. Imagine glancing at your watch and seeing your overnight heart rate, respiratory rate, wrist temperature, blood oxygen level, and sleep duration displayed conveniently in one place. The Vitals app provides a holistic snapshot of your overall health and well-being, empowering you to make informed decisions about your health and fitness routines.

Apple WWDC24 watchOS 11 Cycle Tracking app 240610 inline.jpg.large 2x
Source: Apple

For expecting mothers, watchOS 11 integrates seamlessly with the Health app on iPhone. The Cycle Tracking app on Apple Watch can display gestational age and allow users to log pregnancy symptoms, providing valuable insights throughout their pregnancy journey.

Smarter Stacks for Enhanced Functionality

Apple WWDC24 watchOS 11 Smart Stack Calendar app 240610 inline.jpg.large 2x
Source: Apple

Smart Stacks, a feature that groups relevant watch faces together for easy access, receives an upgrade in watchOS 11. Imagine a Smart Stack that automatically displays the weather forecast in the morning, your workout routine during exercise hours, and upcoming calendar events throughout the day. This functionality leverages on-device intelligence to display the most relevant information at the most opportune time, eliminating the need to manually switch between different watch faces.

Live Activities: Staying Connected in Real-Time

watchOS 11 introduces Live Activities, a new feature that allows users to stay updated on events happening in real-time directly from their wrist. Imagine following the live score of a sporting event, monitoring the progress of a ride-sharing service, or tracking the status of a food delivery order, all without needing to unlock your iPhone. Live Activities provide a convenient way to stay connected to ongoing events without interrupting your workflow.

Introducing the Translate App

watchOS 11 expands communication capabilities with the introduction of the Translate app. Imagine travelling abroad and needing to translate a phrase or sentence on the fly. With the Translate app, you can simply type or dictate a phrase in one language and view the translated text on your watch screen. This functionality can be particularly useful for navigating unfamiliar places, ordering food, or simply breaking down language barriers during your travels.

Enhanced Workout Tracking with Expanded Options

The Workout app on Apple Watch receives an upgrade in watchOS 11. Imagine having access to more structured workout options beyond running, walking, and cycling. With watchOS 11, users can create custom workouts for activities like swimming, strength training, or yoga. Additionally, the ability to set target-based and time-based intervals within workouts allows for a more personalized and goal-oriented fitness experience.

Apple WWDC24 watchOS 11 training load Apple Watch and iPhone 240610 inline.jpg.large 2x
Source: Apple

watchOS 11 also introduces Training Load, a new metric that calculates the intensity and duration of your workouts, providing insights into your overall training effectiveness and recovery needs. Imagine understanding how your workouts are impacting your body and adjusting your training plan accordingly to optimize your performance and prevent injury.

A More Personalized Watch Face

watchOS 11 introduces a redesigned Photos watch face that uses machine learning to automatically curate photos that it thinks will look best as a watch face. Imagine having a dynamic watch face that showcases your favourite memories throughout the day. Additionally, users can customize the watch face with different font and colour options to further personalize their Apple Watch experience.

Beyond the Headline Features: Minor Enhancements

While personalization features, the Vitals app, Live Activities, and the Translate app take centre stage in watchOS 11, there are additional enhancements worth mentioning. Users can now send and receive Apple Cash by holding the Apple Watch near another watch or iPhone with Tap to Cash, eliminating the need to carry physical cash or a debit card for small transactions. Additionally, offline turn-by-turn navigation for custom walking routes and hikes is now available for all U.S. national parks, allowing users to explore these natural wonders without relying on a cellular connection.

You’ll Be Able to Regenerate Your Teeth Soon Thanks to a New Groundbreaking Drug

A new era in dental care may be dawning, thanks to a revolutionary drug that has been approved for the first time in human trials. This drug, developed by a research team at Kyoto University, Japan, has the potential to regrow teeth – a feat previously only possible in our imaginations.

The drug works by targeting a specific protein called USAG-1 (uterine sensitization-associated gene-1). This protein acts as a natural inhibitor of tooth growth. By deactivating USAG-1, the drug essentially removes the roadblock and allows for the resumption of tooth development. The deactivated USAG-1 protein no longer hinders the interaction between bone morphogenetic proteins (BMPs) and other cellular processes essential for tooth formation. The activation of BMP signalling then triggers the growth of new bone and dental tissue.

rafael rocha UGFkfsj 4z4 unsplash
Photo by Rafael Rocha on Unsplash

The research team led by Dr. Katsu Takahashi, a molecular biologist and dentist, has been working on this concept since 2005. Their initial research focused on understanding the role of USAG-1 in tooth development. Following these discoveries, they conducted successful experiments in mice with tooth agenesis, a condition where teeth fail to develop naturally. These studies demonstrated that blocking USAG-1 with an antibody could stimulate tooth regrowth.

Building upon the success in animal models, researchers have developed a new iteration of the drug specifically for human use. This injectable drug has now been approved for human trials, with the first phase expected to begin in September 2024 at Kyoto University Hospital. The trial will involve 30 male participants between the ages of 30 and 64 who are missing at least one molar tooth.

It is important to note that this is a Phase 1 trial, the initial stage of human testing. The primary focus will be on assessing the drug’s safety and potential side effects in humans. Efficacy, or the drug’s ability to regrow teeth, will be a secondary objective in this phase. Even if successful, further trials will be required to determine the long-term effectiveness and optimal treatment protocols.

enis yavuz VC5lS43bwJo unsplash
Photo by Enis Yavuz on Unsplash

The potential impact of this research is significant. If successful, this drug could revolutionize dentistry, offering a permanent solution for tooth loss. This could potentially eliminate the need for traditional dental implants, bridges, and dentures, all of which come with their own limitations and drawbacks. However, it is important to manage expectations, as the technology is still in its early stages.

「先天性無歯症の"歯生え薬"開発」第97回 学術講演会 ~医学研究所北野病院(大阪市北区)~

The upcoming human trial will be a crucial step in evaluating the safety and efficacy of this groundbreaking drug. While the potential for tooth regeneration is exciting, researchers emphasize the importance of a rigorous scientific process to ensure the development of a safe and reliable treatment option for patients suffering from tooth loss.